Shareholders who purchased shares of HUM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: July 27, 2022 to January 24, 2024 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HUM during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lif ...

Group 1 - A class action lawsuit has been filed against Humana Inc. on behalf of shareholders who purchased common stock between July 27, 2022, and January 24, 2024, with a deadline for lead plaintiff motions set for August 2, 2024 [1][3] - The lawsuit alleges that Humana misled investors regarding its business operations, specifically downplaying pressures on adjusted earnings per share (EPS) due to increased medical costs from pent-up demand for healthcare procedures [2][5] - The lawsuit claims that when the true details about Humana's financial pressures became public, investors suffered damages [5] Group 2 - The Rosen Law Firm is investigating allegations that Humana made false and misleading statements and failed to disclose material adverse facts about its business [2][5] - Shareholders can join the class action without participating in the case, remaining as absent class members if they choose [3][6] - All representation in the lawsuit is on a contingency fee basis, meaning shareholders pay no fees or expenses [6]

Humana Inc. (HUM) is set to report its second-quarter 2024 results on Jul 31, before the opening bell. The Zacks Consensus Estimate for second-quarter earnings per share of $5.89 indicates a decrease of 34.1% from the prior-year reported number of $8.94. The estimate remained stable over the past week. The consensus mark for second-quarter revenues of $28.6 billion indicates an 11.3% increase from the year-ago reported figure. Image Source: Zacks Investment Research Humana beat the earnings estimate in thre ...

Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock. The collective assessment of analysts points to an estimated 'Revenues- Investment income (loss)' of $304.69 million. The esti ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Humana Inc. (NYSE: HUM) between July 27, 2022 and January 24, 2024, both dates inclusive (the "Class Period"), of the important August 2, 2024 lead plaintiff deadline. WHAT TO DO NEXT: To join the Humana class action, go to https://rosenlegal.com/submit-form/? case_id=25679 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit ha ...

NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Humana Inc. ("Humana" or the "Company") (NYSE: HUM) and reminds investors of the August 2, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading st ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Humana To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in Humana stock or options between July 27, 2022 and January 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faru ...

NEW YORK, July 25, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Humana Inc. (NYSE: HUM). CONTACT US HERE: ALLEGATIONS: According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that: Specifically, defendants downplayed pressures on the Company's adjusted earnings per share resulting from increased medical costs associated with pent-up demand for healthcare procedures which, contrary to the Company's assurances, re ...

Walmart, which announced three months ago it was shuttering its retail health clinics and its ... [+] telehealth operation, said Wednesday that Humana's healthcare services business, CenterWell "plans to lease clinical space and open senior-focused primary care centers at 23 Walmart Supercenter retail stores in Florida, Georgia, Missouri and Texas," the companies said. Walmart/Wesley Hitt Humana's healthcare services business, CenterWell, plans to lease and open senior-focused primary care centers at 23 for ...

Klaus Vedfelt Investment Thesis Back in April, I shared a note with Seeking Alpha readers on the Louisville, Kentucky headquartered health insurance giant Humana (NYSE:HUM), giving the company and its stock a "buy" recommendation. My thesis was on some levels straightforward - "buy the dip". When Humana's business experiences setbacks, the market typically panics, and dumps the stock as fast as it can, but typically, within a few months, the stock price has fully recovered and trades at a higher value than ...